Selinexor, a selective inhibitor of nuclear export, inhibits human neutrophil extracellular trap formation in vitro.
Ontology highlight
ABSTRACT: Neutrophils are central players in the innate immune system. To protect against invading pathogens, neutrophils can externalize chromatin to create neutrophil extracellular traps (NETs). While NETs are critical to host defense, they also have deleterious effects, and dysregulation of NETs formation has been implicated in autoimmune diseases, atherosclerosis and thrombotic conditions, cancer progression and dissemination, and acute respiratory distress syndrome. Here, we report that selinexor, a first-in-class selective inhibitor of nuclear export approved for the treatment of multiple myeloma and diffuse large B-cell lymphoma, markedly suppressed the release of NETs in vitro. Furthermore, we demonstrate a significant inhibitory effect of selinexor on NETs formation, but not on oxida
SUBMITTER: Baron S
PROVIDER: S-EPMC9730241 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA